BIMG-12. [18F]FLUCICLOVINE PET TO DISTINGUISH PSEUDOPROGRESSION FROM TUMOR PROGRESSION IN POST-TREATMENT GLIOBLASTOMA

PURPOSE: Differentiation of true tumor progression from pseudoprogression (PsP) is a major unmet need in patients with glioblastoma (GBM). [(18)F]Fluciclovine is a synthetic amino acid PET radiotracer that is FDA approved in the setting of biochemical recurrence in prostate cancer. The aim of this s...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neurooncol Adv
Hauptverfasser: Nabavizadeh, Ali, Doot, Robert, Young, Anthony, Nasrallah, MacLean, Ware, Jeffrey, Schubert, Erin, Henderson, Fraser, Pantel, Austin, Desai, Arati, Bagley, Stephen, O’Rourke, Donald, Brem, Steven
Format: Artigo
Sprache:Inglês
Veröffentlicht: Oxford University Press 2021
Schlagworte:
Supplement Abstracts
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7992241/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/noajnl/vdab024.011
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge